X hits on this document

43 views

0 shares

0 downloads

0 comments

8 / 12

4.118-X§4.118—Schedule of ratings–skin      4.118-X

disability.

7822  Papulosquamous disorders not listed elsewhere (including lichen planus, large or

small plaque parapsoriasis, pityriasis lichenoides et varioliformis acuta

(PLEVA), lymphomatoid papulosus, and pityriasis rubra pilaris (PRP)):

More than 40 percent of the entire body or more than 40 percent of

exposed areas affected, and; constant or near-constant systemic

medications or intensive light therapy required during the past

12-month period60

20 to 40 percent of the entire body or 20 to 40 percent of exposed

areas affected, or; systemic therapy or intensive light therapy required

for a total duration of six weeks or more, but not constantly, during

the past 12-month period30

At least 5 percent, but less than 20 percent, of the entire body, or at

least 5 percent, but less than 20 percent, of exposed areas affected,

or; systemic therapy or intensive light therapy required for a total

duration of less than six weeks during the past 12-month period10

Less than 5 percent of the entire body or exposed areas affected, and;

no more than topical therapy required during the past 12-month

period0

Or rate as disfigurement of the head, face, or neck (DC 7800) or scars (DC’s

7801, 7802, 7803, 7804, or 7805), depending upon the predominant

disability.

7823  Vitiligo:

With exposed areas affected10

With no exposed areas affected0

7824 Diseases of keratinization (including icthyoses, Darier’s disease, and palmoplantar

keratoderma):

With either generalized cutaneous involvement or systemic

manifestations, and; constant or near-constant systemic medication,

such as immunosuppressive retinoids, required during the past

12-month period60

With either generalized cutaneous involvement or systemic

manifestations, and; intermittent systemic medication, such as

immunosuppressive retinoids, required for a total duration of six

weeks or more, but not constantly, during the past 12-month period30

With localized or episodic cutaneous involvement and intermittent

systemic medication, such as immunosuppressive retinoids, required

for a total duration of less than six weeks during the past 12-month

(No. 51  2/5/12)

Document info
Document views43
Page views43
Page last viewedSun Dec 11 00:59:32 UTC 2016
Pages12
Paragraphs368
Words3750

Comments